Evaluate a Norstella company
Evaluate a Norstella company
Back to all episodes
Cardiovascular

Where cardiovascular growth, pipeline and deals are heading

Cardiovascular sales are forecast to grow 11% a year through 2032, and growth is concentrated in new entrants. Evaluate’s experts discuss the new modalities, deals, and patent exposure behind the headline numbers.
23 minutes

–

On demand

MA
Mary Anderson
Senior Consultant
JM
Jessica Merrill
Senior Editor, Scrip

Register free to unlock

Full episode video

Companion short report

Blog post & thought leadership

Scroll down to register — one form unlocks everything on this page.

Register for free access
Notify me when new episodes are dropping







Episode Video

Watch now

23 minutes

What the episode covers

  • Cardiovascular sales are forecast to grow at 11% CAGR through 2032
  • Growth is concentrated in new entrants and recent launches
  • Merck set to become the largest cardiovascular company by 2032
  • Loss of exclusivity threatens top players like BMS and J&J
  • Oral PCSK9 inhibitors drive 43% annual growth in trial starts
  • Deal volumes have fallen but deal structures are changing

Additional content

Go Deeper

Report

Report

Market Trends, Pipeline Evolution, and Future Growth Drivers

Cardiovascular revenues are forecast to reach close to $100billion by 2032. But there is a reshuffle of the companies at the top of that market, and a range of new modalities driving that growth.
Blog

Blog

Cardiovascular sales set to grow 11% a year as new leaders emerge

Short on time? Check out the blog post. Which companies will lead cardiovascular sales by 2032? Explore the shifts in modalities, Lp(a) and dealmaking.

Up next in the series

Evaluate Spotlight: Cell and Gene

Notify me when available
All episodes

Evaluate Consulting

Data into direction. Partnership into purpose.

Want to go deeper? Evaluate’s consulting team provides bespoke analysis on market sizing, pipeline strategy, BD&L, and competitive intelligence.

Find out more
Evaluate White Logo
Instagram Linkedin